• +1-646-491-9876
    • +91-20-67278686

    Search

    Global Biologics and Biosimilars Industry 2016 Market Research Report

    Global Biologics and Biosimilars Industry 2016 Market Research Report

    • Report Code ID: RW0001128662
    • Category Life Sciences
    • No. of Pages 158
    • Publication Month Feb-16
    • Publisher Name QY Research
    The Global Biologics and Biosimilars Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Biologics and Biosimilars industry.

    Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biologics and Biosimilars market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status.

    Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added.

    Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What's more, the Biologics and Biosimilars industry development trends and marketing channels are analyzed.

    Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

    In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
    Table of Contents

    1 Industry Overview of Biologics and Biosimilars
    1.1 Definition and Specifications of Biologics and Biosimilars
    1.1.1 Definition of Biologics and Biosimilars
    1.1.2 Specifications of Biologics and Biosimilars
    1.2 Classification of Biologics and Biosimilars
    1.3 Applications of Biologics and Biosimilars
    1.4 Industry Chain Structure of Biologics and Biosimilars
    1.5 Industry Overview and Major Regions Status of Biologics and Biosimilars
    1.5.1 Industry Overview of Biologics and Biosimilars
    1.5.2 Global Major Regions Status of Biologics and Biosimilars
    1.6 Industry Policy Analysis of Biologics and Biosimilars
    1.7 Industry News Analysis of Biologics and Biosimilars

    2 Manufacturing Cost Structure Analysis of Biologics and Biosimilars
    2.1 Raw Material Suppliers and Price Analysis of Biologics and Biosimilars
    2.2 Equipment Suppliers and Price Analysis of Biologics and Biosimilars
    2.3 Labor Cost Analysis of Biologics and Biosimilars
    2.4 Other Costs Analysis of Biologics and Biosimilars
    2.5 Manufacturing Cost Structure Analysis of Biologics and Biosimilars
    2.6 Manufacturing Process Analysis of Biologics and Biosimilars

    3 Technical Data and Manufacturing Plants Analysis of Biologics and Biosimilars
    3.1 Capacity and Commercial Production Date of Global Biologics and Biosimilars Major Manufacturers in 2015
    3.2 Manufacturing Plants Distribution of Global Biologics and Biosimilars Major Manufacturers in 2015
    3.3 R&D Status and Technology Source of Global Biologics and Biosimilars Major Manufacturers in 2015
    3.4 Raw Materials Sources Analysis of Global Biologics and Biosimilars Major Manufacturers in 2015

    4 Capacity, Production and Revenue Analysis of Biologics and Biosimilars by Regions, Types and Manufacturers
    4.1 Global Capacity, Production and Revenue of Biologics and Biosimilars by Regions 2011-2016
    4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Biologics and Biosimilars 2011-2016
    4.3 Global Capacity, Production and Revenue of Biologics and Biosimilars by Types 2011-2016
    4.4 Global Capacity, Production and Revenue of Biologics and Biosimilars by Manufacturers 2011-2016

    5 Price, Cost, Gross and Gross Margin Analysis of Biologics and Biosimilars by Regions, Types and Manufacturers
    5.1 Price, Cost, Gross and Gross Margin Analysis of Biologics and Biosimilars by Regions 2011-2016
    5.2 Price, Cost, Gross and Gross Margin Analysis of Biologics and Biosimilars by Types 2011-2016
    5.3 Price, Cost, Gross and Gross Margin Analysis of Biologics and Biosimilars by Manufacturers 2011-2016

    6 Consumption Volume, Consumption Value and Sale Price Analysis of Biologics and Biosimilars by Regions, Types and Applications
    6.1 Global Consumption Volume and Consumption Value of Biologics and Biosimilars by Regions 2011-2016
    6.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Biologics and Biosimilars 2011-2016
    6.3 Global Consumption Volume and Consumption Value of Biologics and Biosimilars by Types 2011-2016
    6.4 Global Consumption Volume and Consumption Value of Biologics and Biosimilars by Applications 2011-2016
    6.5 Sale Price of Biologics and Biosimilars by Regions 2011-2016
    6.6 Sale Price of Biologics and Biosimilars by Types 2011-2016
    6.7 Sale Price of Biologics and Biosimilars by Applications 2011-2016
    6.8 Market Share Analysis of Biologics and Biosimilars by Different Sale Price Levels

    7 Supply, Import, Export and Consumption Analysis of Biologics and Biosimilars
    7.1 Supply, Consumption and Gap of Biologics and Biosimilars 2011-2016
    7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biologics and Biosimilars 2011-2016
    7.3 United States Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biologics and Biosimilars 2011-2016
    7.4 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biologics and Biosimilars 2011-2016
    7.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biologics and Biosimilars 2011-2016
    7.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biologics and Biosimilars 2011-2016

    8 Major Manufacturers Analysis of Biologics and Biosimilars
    8.1 Roche
    8.1.1 Company Profile
    8.1.2 Product Picture and Specifications
    8.1.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.1.4 Contact Information

    8.2 Amgen
    8.2.1 Company Profile
    8.2.2 Product Picture and Specifications
    8.2.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.2.4 Contact Information

    8.3 AbbVie
    8.3.1 Company Profile
    8.3.2 Product Picture and Specifications
    8.3.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.3.4 Contact Information

    8.4 Sanofi-Aventis
    8.4.1 Company Profile
    8.4.2 Product Picture and Specifications
    8.4.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.4.4 Contact Information

    8.5 Johnson & Johnson
    8.5.1 Company Profile
    8.5.2 Product Picture and Specifications
    8.5.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.5.4 Contact Information

    8.6 Pfizer
    8.6.1 Company Profile
    8.6.2 Product Picture and Specifications
    8.6.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.6.4 Contact Information

    8.7 Novo Nordisk
    8.7.1 Company Profile
    8.7.2 Product Picture and Specifications
    8.7.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.7.4 Contact Information

    8.8 Eli Lilly
    8.8.1 Company Profile
    8.8.2 Product Picture and Specifications
    8.8.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.8.4 Contact Information

    8.9 Novartis
    8.9.1 Company Profile
    8.9.2 Product Picture and Specifications
    8.9.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.9.4 Contact Information

    8.10 Merck
    8.10.1 Company Profile
    8.10.2 Product Picture and Specifications
    8.10.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.10.4 Contact Information

    8.11 3sbio
    8.11.1 Company Profile
    8.11.2 Product Picture and Specifications
    8.11.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.11.4 Contact Information

    8.12 Changchun High Tech
    8.12.1 Company Profile
    8.12.2 Product Picture and Specifications
    8.12.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.12.4 Contact Information

    8.13 CP Guojian Pharmacy
    8.13.1 Company Profile
    8.13.2 Product Picture and Specifications
    8.13.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.13.4 Contact Information

    8.14 Biotech Pharma
    8.14.1 Company Profile
    8.14.2 Product Picture and Specifications
    8.14.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.14.4 Contact Information

    8.15 Gelgen Biopharma
    8.15.1 Company Profile
    8.15.2 Product Picture and Specifications
    8.15.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.15.4 Contact Information

    8.16 Innovent
    8.16.1 Company Profile
    8.16.2 Product Picture and Specifications
    8.16.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.16.4 Contact Information

    8.17 Tong Hua Dong Bao Group
    8.17.1 Company Profile
    8.17.2 Product Picture and Specifications
    8.17.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.17.4 Contact Information

    8.18 Ganlee
    8.18.1 Company Profile
    8.18.2 Product Picture and Specifications
    8.18.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.18.4 Contact Information

    8.19 United Laboratories
    8.19.1 Company Profile
    8.19.2 Product Picture and Specifications
    8.19.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.19.4 Contact Information

    8.20 Teva Pharmaceutical
    8.20.1 Company Profile
    8.20.2 Product Picture and Specifications
    8.20.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.20.4 Contact Information

    8.21 MYLAN
    8.21.1 Company Profile
    8.21.2 Product Picture and Specifications
    8.21.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.21.4 Contact Information

    9 Marketing Trader or Distributor Analysis of Biologics and Biosimilars
    9.1 Marketing Channels Status of Biologics and Biosimilars
    9.2 Traders or Distributors with Contact Information of Biologics and Biosimilars by Regions
    9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Biologics and Biosimilars
    9.4 Regional Import, Export and Trade Analysis of Biologics and Biosimilars

    10 Industry Chain Analysis of Biologics and Biosimilars
    10.1 Upstream Major Raw Materials Suppliers Analysis of Biologics and Biosimilars
    10.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Biologics and Biosimilars
    10.1.2 Major Raw Materials Suppliers with Supply Volume Analysis of Biologics and Biosimilars by Regions
    10.2 Upstream Major Equipment Suppliers Analysis of Biologics and Biosimilars
    10.2.1 Major Equipment Suppliers with Contact Information Analysis of Biologics and Biosimilars
    10.2.2 Major Equipment Suppliers with Product Pictures Analysis of Biologics and Biosimilars by Regions
    10.3 Downstream Major Consumers Analysis of Biologics and Biosimilars
    10.3.1 Major Consumers with Contact Information Analysis of Biologics and Biosimilars
    10.3.2 Major Consumers with Consumption Volume Analysis of Biologics and Biosimilars by Regions
    10.4 Supply Chain Relationship Analysis of Biologics and Biosimilars

    11 Development Trend of Analysis of Biologics and Biosimilars
    11.1 Capacity, Production and Revenue Forecast of Biologics and Biosimilars by Regions and Types
    11.1.1 Global Capacity, Production and Revenue of Biologics and Biosimilars by Regions 2016-2021
    11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Biologics and Biosimilars 2016-2021
    11.1.3 Global Capacity, Production and Revenue of Biologics and Biosimilars by Types 2016-2021
    11.2 Consumption Volume and Consumption Value Forecast of Biologics and Biosimilars by Regions, Types and Applications
    11.2.1 Global Consumption Volume and Consumption Value of Biologics and Biosimilars by Regions 2016-2021
    11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Biologics and Biosimilars 2016-2021
    11.2.3 Global Consumption Volume and Consumption Value of Biologics and Biosimilars by Types 2016-2021
    11.2.4 Global Consumption Volume and Consumption Value of Biologics and Biosimilars by Applications 2016-2021
    11.3 Supply, Import, Export and Consumption Forecast of Biologics and Biosimilars
    11.3.1 Supply, Consumption and Gap of Biologics and Biosimilars 2016-2021
    11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biologics and Biosimilars 2016-2021
    11.3.3 United States Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biologics and Biosimilars 2016-2021
    11.3.4 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biologics and Biosimilars 2016-2021
    11.3.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biologics and Biosimilars 2016-2021
    11.3.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biologics and Biosimilars 2016-2021

    12 New Project Investment Feasibility Analysis of Biologics and Biosimilars
    12.1 New Project SWOT Analysis of Biologics and Biosimilars
    12.2 New Project Investment Feasibility Analysis of Biologics and Biosimilars

    13 Conclusion of the Global Biologics and Biosimilars Industry 2016 Market Research Report




    List of Tables and Figures
    Figure Picture of Biologics and Biosimilars
    Table Product Specifications of Biologics and Biosimilars
    Table Classification of Biologics and Biosimilars
    Figure Global Production Market Share of Biologics and Biosimilars by Types in 2015
    Table Applications of Biologics and Biosimilars
    Figure Global Consumption Volume Market Share of Biologics and Biosimilars by Applications in 2015
    Figure Industry Chain Structure of Biologics and Biosimilars
    Table Global Biologics and Biosimilars Major Manufacturers
    Table Global Major Regions Biologics and Biosimilars Development Status
    Table Industry Policy of Biologics and Biosimilars
    Table Industry News List of Biologics and Biosimilars
    Table Raw Material Suppliers and Price Analysis
    Table Equipment Suppliers and Price Analysis
    Table Manufacturing Cost Structure Analysis of Biologics and Biosimilars in 2015
    Figure Manufacturing Process Analysis of Biologics and Biosimilars
    Table Capacity (K Units) and Commercial Production Date of Global Biologics and Biosimilars Major Manufacturers in 2015
    Table Manufacturing Plants Distribution of Global Biologics and Biosimilars Major Manufacturers in 2015
    Table R&D Status and Technology Source of Global Biologics and Biosimilars Major Manufacturers in 2015
    Table Raw Materials Sources Analysis of Global Biologics and Biosimilars Major Manufacturers in 2015
    Table Global Capacity (K Units) of Biologics and Biosimilars by Regions 2011-2016
    Figure Global Capacity Market Share of Biologics and Biosimilars by Regions in 2011
    Figure Global Capacity Market Share of Biologics and Biosimilars by Regions in 2015
    Table Global Production (K Units) of Biologics and Biosimilars by Regions 2011-2016
    Figure Global Production Market Share of Biologics and Biosimilars by Regions in 2011
    Figure Global Production Market Share of Biologics and Biosimilars by Regions in 2015
    Table Global Revenue (M USD) of Biologics and Biosimilars by Regions 2011-2016
    Figure Global Revenue Market Share of Biologics and Biosimilars by Regions in 2011
    Figure Global Revenue Market Share of Biologics and Biosimilars by Regions in 2015
    Figure Global Capacity (K Units), Production (K Units) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure Global Capacity Utilization Rate of Biologics and Biosimilars 2011-2016
    Figure Global Revenue (M USD) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure United States Capacity Utilization Rate of Biologics and Biosimilars 2011-2016
    Figure United States Revenue (M USD) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure EU Capacity (K Units), Production (K Units) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure EU Capacity Utilization Rate of Biologics and Biosimilars 2011-2016
    Figure EU Revenue (M USD) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure China Capacity (K Units), Production (K Units) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure China Capacity Utilization Rate of Biologics and Biosimilars 2011-2016
    Figure China Revenue (M USD) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure Japan Capacity (K Units), Production (K Units) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure Japan Capacity Utilization Rate of Biologics and Biosimilars 2011-2016
    Figure Japan Revenue (M USD) and Growth Rate of Biologics and Biosimilars 2011-2016
    Table Global Capacity (K Units) of Biologics and Biosimilars by Types 2011-2016
    Figure Global Capacity Market Share of Biologics and Biosimilars by Types in 2011
    Figure Global Capacity Market Share of Biologics and Biosimilars by Types in 2015
    Table Global Production (K Units) of Biologics and Biosimilars by Types 2011-2016
    Figure Global Production Market Share of Biologics and Biosimilars by Types in 2011
    Figure Global Production Market Share of Biologics and Biosimilars by Types in 2015
    Table Global Revenue (M USD) of Biologics and Biosimilars by Types 2011-2016
    Figure Global Revenue Market Share of Biologics and Biosimilars by Types in 2011
    Figure Global Revenue Market Share of Biologics and Biosimilars by Types in 2015
    Table Global and Major Manufacturers Capacity (K Units) of Biologics and Biosimilars 2011-2016
    Table Global Capacity Market Share of Biologics and Biosimilars Major Manufacturers 2011-2016
    Figure Global Capacity Market Share of Biologics and Biosimilars Major Manufacturers in 2011
    Figure Global Capacity Market Share of Biologics and Biosimilars Major Manufacturers in 2015
    Table Global and Major Manufacturers Production (K Units) of Biologics and Biosimilars 2011-2016
    Table Global Production Market Share of Biologics and Biosimilars Major Manufacturers 2011-2016
    Figure Global Production Market Share of Biologics and Biosimilars Major Manufacturers in 2011
    Figure Global Production Market Share of Biologics and Biosimilars Major Manufacturers in 2015
    Table Global and Major Manufacturers Revenue (M USD) of Biologics and Biosimilars 2011-2016
    Table Global Revenue Market Share of Biologics and Biosimilars Major Manufacturers 2011-2016
    Figure Global Revenue Market Share of Biologics and Biosimilars Major Manufacturers in 2011
    Figure Global Revenue Market Share of Biologics and Biosimilars Major Manufacturers in 2015
    Table Price (USD/Unit) of Biologics and Biosimilars by Regions 2011-2016
    Figure Price (USD/Unit) of Biologics and Biosimilars by Regions in 2015
    Table Cost (USD/Unit) of Biologics and Biosimilars by Regions 2011-2016
    Figure Cost (USD/Unit) of Biologics and Biosimilars by Regions in 2015
    Table Gross (USD/Unit) of Biologics and Biosimilars by Regions 2011-2016
    Figure Gross (USD/Unit) of Biologics and Biosimilars by Regions in 2015
    Table Gross Margin of Biologics and Biosimilars by Regions 2011-2016
    Figure Gross Margin of Biologics and Biosimilars by Regions in 2015
    Table Price (USD/Unit) of Biologics and Biosimilars by Types 2011-2016
    Figure Price (USD/Unit) of Biologics and Biosimilars by Types in 2015
    Table Cost (USD/Unit) of Biologics and Biosimilars by Types 2011-2016
    Figure Cost (USD/Unit) of Biologics and Biosimilars by Types in 2015
    Table Gross (USD/Unit) of Biologics and Biosimilars by Types 2011-2016
    Figure Gross (USD/Unit) of Biologics and Biosimilars by Types in 2015
    Table Gross Margin of Biologics and Biosimilars by Types 2011-2016
    Figure Gross Margin of Biologics and Biosimilars by Types in 2015
    Table Price (USD/Unit) of Biologics and Biosimilars by Manufacturers 2011-2016
    Figure Price (USD/Unit) of Biologics and Biosimilars by Manufacturers in 2015
    Table Cost (USD/Unit) of Biologics and Biosimilars by Manufacturers 2011-2016
    Figure Cost (USD/Unit) of Biologics and Biosimilars by Manufacturers in 2015
    Table Gross (USD/Unit) of Biologics and Biosimilars by Manufacturers 2011-2016
    Figure Gross (USD/Unit) of Biologics and Biosimilars by Manufacturers in 2015
    Table Gross Margin of Biologics and Biosimilars by Manufacturers 2011-2016
    Figure Gross Margin of Biologics and Biosimilars by Manufacturers in 2015
    Table Global Consumption Volume (K Units) of Biologics and Biosimilars by Regions 2011-2016
    Figure Global Consumption Volume Market Share of Biologics and Biosimilars by Regions in 2011
    Figure Global Consumption Volume Market Share of Biologics and Biosimilars by Regions in 2015
    Table Global Consumption Value (M USD) of Biologics and Biosimilars by Regions 2011-2016
    Figure Global Consumption Value Market Share of Biologics and Biosimilars by Regions in 2011
    Figure Global Consumption Value Market Share of Biologics and Biosimilars by Regions in 2015
    Figure Global Consumption Volume (K Units) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure Global Consumption Value (M USD) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure United States Consumption Volume (K Units) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure United States Consumption Value (M USD) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure EU Consumption Volume (K Units) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure EU Consumption Value (M USD) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure China Consumption Volume (K Units) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure China Consumption Value (M USD) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure Japan Consumption Volume (K Units) and Growth Rate of Biologics and Biosimilars 2011-2016
    Figure Japan Consumption Value (M USD) and Growth Rate of Biologics and Biosimilars 2011-2016
    Table Global Consumption Volume (K Units) of Biologics and Biosimilars by Types 2011-2016
    Figure Global Consumption Volume Market Share of Biologics and Biosimilars by Types in 2011
    Figure Global Consumption Volume Market Share of Biologics and Biosimilars by Types in 2015
    Table Global Consumption Value (M USD) of Biologics and Biosimilars by Types 2011-2016
    Figure Global Consumption Value Market Share of Biologics and Biosimilars by Types in 2011
    Figure Global Consumption Value Market Share of Biologics and Biosimilars by Types in 2015
    Table Global Consumption Volume (K Units) of Biologics and Biosimilars by Applications 2011-2016
    Figure Global Consumption Volume Market Share of Biologics and Biosimilars by Applications in 2011
    Figure Global Consumption Volume Market Share of Biologics and Biosimilars by Applications in 2015
    Table Global Consumption Value (M USD) of Biologics and Biosimilars by Applications 2011-2016
    Figure Global Consumption Value Market Share of Biologics and Biosimilars by Applications in 2011
    Figure Global Consumption Value Market Share of Biologics and Biosimilars by Applications in 2015
    Table Sale Price (USD/Unit) of Biologics and Biosimilars by Regions 2011-2016
    Figure Sale Price (USD/Unit) of Biologics and Biosimilars by Regions in 2015
    Table Sale Price (USD/Unit) of Biologics and Biosimilars by Types 2011-2016
    Figure Sale Price (USD/Unit) of Biologics and Biosimilars by Types in 2015
    Table Sale Price (USD/Unit) of Biologics and Biosimilars by Applications 2011-2016
    Figure Sale Price (USD/Unit) of Biologics and Biosimilars by Applications in 2015
    Table Market Share of Biologics and Biosimilars by Different Sale Price Levels
    Table Global Supply, Consumption and Gap of Biologics and Biosimilars 2011-2016 (K Units)
    Table United States Supply, Consumption and Gap of Biologics and Biosimilars 2011-2016 (K Units)
    Table EU Supply, Consumption and Gap of Biologics and Biosimilars 2011-2016 (K Units)
    Table China Supply, Consumption and Gap of Biologics and Biosimilars 2011-2016 (K Units)
    Table Japan Supply, Consumption and Gap of Biologics and Biosimilars 2011-2016 (K Units)
    Table Global Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2011-2016
    Table United States Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2011-2016
    Table United States Supply, Import, Export and Consumption of Biologics and Biosimilars 2011-2016 (K Units)
    Table EU Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2011-2016
    Table EU Supply, Import, Export and Consumption of Biologics and Biosimilars 2011-2016 (K Units)
    Table China Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2011-2016
    Table China Supply, Import, Export and Consumption of Biologics and Biosimilars 2011-2016 (K Units)
    Table Japan Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Biologics and Biosimilars 2011-2016
    Table Japan Supply, Import, Export and Consumption of Biologics and Biosimilars 2011-2016 (K Units)
    Table Roche Information List
    Figure Biologics and Biosimilars Picture and Specifications of Roche
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Roche 2011-2016
    Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Roche 2011-2016
    Figure Biologics and Biosimilars Production (K Units) and Global Market Share of Roche 2011-2016
    Table Amgen Information List
    Figure Biologics and Biosimilars Picture and Specifications of Amgen
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Amgen 2011-2016
    Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Amgen 2011-2016
    Figure Biologics and Biosimilars Production (K Units) and Global Market Share of Amgen 2011-2016
    Table AbbVie Information List
    Figure Biologics and Biosimilars Picture and Specifications of AbbVie
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AbbVie 2011-2016
    Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of AbbVie 2011-2016
    Figure Biologics and Biosimilars Production (K Units) and Global Market Share of AbbVie 2011-2016
    Table Sanofi-Aventis Information List
    Figure Biologics and Biosimilars Picture and Specifications of Sanofi-Aventis
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi-Aventis 2011-2016
    Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Sanofi-Aventis 2011-2016
    Figure Biologics and Biosimilars Production (K Units) and Global Market Share of Sanofi-Aventis 2011-2016
    Table Johnson & Johnson Information List
    Figure Biologics and Biosimilars Picture and Specifications of Johnson & Johnson
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2011-2016
    Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Johnson & Johnson 2011-2016
    Figure Biologics and Biosimilars Production (K Units) and Global Market Share of Johnson & Johnson 2011-2016
    Table Pfizer Information List
    Figure Biologics and Biosimilars Picture and Specifications of Pfizer
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2011-2016
    Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Pfizer 2011-2016
    Figure Biologics and Biosimilars Production (K Units) and Global Market Share of Pfizer 2011-2016
    Table Novo Nordisk Information List
    Figure Biologics and Biosimilars Picture and Specifications of Novo Nordisk
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novo Nordisk 2011-2016
    Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Novo Nordisk 2011-2016
    Figure Biologics and Biosimilars Production (K Units) and Global Market Share of Novo Nordisk 2011-2016
    Table Eli Lilly Information List
    Figure Biologics and Biosimilars Picture and Specifications of Eli Lilly
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Eli Lilly 2011-2016
    Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Eli Lilly 2011-2016
    Figure Biologics and Biosimilars Production (K Units) and Global Market Share of Eli Lilly 2011-2016
    Table Novartis Information List
    Figure Biologics and Biosimilars Picture and Specifications of Novartis
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2011-2016
    Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Novartis 2011-2016
    Figure Biologics and Biosimilars Production (K Units) and Global Market Share of Novartis 2011-2016
    Table Merck Information List
    Figure Biologics and Biosimilars Picture and Specifications of Merck
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Merck 2011-2016
    Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Merck 2011-2016
    Figure Biologics and Biosimilars Production (K Units) and Global Market Share of Merck 2011-2016
    Table 3sbio Information List
    Figure Biologics and Biosimilars Picture and Specifications of 3sbio
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of 3sbio 2011-2016
    Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of 3sbio 2011-2016
    Figure Biologics and Biosimilars Production (K Units) and Global Market Share of 3sbio 2011-2016
    Table Changchun High Tech Information List
    Figure Biologics and Biosimilars Picture and Specifications of Changchun High Tech
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Changchun High Tech 2011-2016
    Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Changchun High Tech 2011-2016
    Figure Biologics and Biosimilars Production (K Units) and Global Market Share of Changchun High Tech 2011-2016
    Table CP Guojian Pharmacy Information List
    Figure Biologics and Biosimilars Picture and Specifications of CP Guojian Pharmacy
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of CP Guojian Pharmacy 2011-2016
    Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of CP Guojian Pharmacy 2011-2016
    Figure Biologics and Biosimilars Production (K Units) and Global Market Share of CP Guojian Pharmacy 2011-2016
    Table Biotech Pharma Information List
    Figure Biologics and Biosimilars Picture and Specifications of Biotech Pharma
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biotech Pharma 2011-2016
    Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Biotech Pharma 2011-2016
    Figure Biologics and Biosimilars Production (K Units) and Global Market Share of Biotech Pharma 2011-2016
    Table Gelgen Biopharma Information List
    Figure Biologics and Biosimilars Picture and Specifications of Gelgen Biopharma
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Gelgen Biopharma 2011-2016
    Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Gelgen Biopharma 2011-2016
    Figure Biologics and Biosimilars Production (K Units) and Global Market Share of Gelgen Biopharma 2011-2016
    Table Innovent Information List
    Figure Biologics and Biosimilars Picture and Specifications of Innovent
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Innovent 2011-2016
    Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Innovent 2011-2016
    Figure Biologics and Biosimilars Production (K Units) and Global Market Share of Innovent 2011-2016
    Table Tong Hua Dong Bao Group Information List
    Figure Biologics and Biosimilars Picture and Specifications of Tong Hua Dong Bao Group
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Tong Hua Dong Bao Group 2011-2016
    Figure Biologics and Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Tong Hua Dong Bao Group 2011-2016
    Figure Biologics and Biosimilars Production (K Units) and Global Market Share of Tong Hua Dong Bao Group 2011-2016
    Table Ganlee Information List
    Figure Biologics and Biosimilars Picture and Specifications of Ganlee
    Table Biologics and Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Ganlee 2011-2

    Request for Sample

    Report Url http://reportsweb.com/Global-Biologics-and-Biosimilars-Industry-2016-Market-Research-Report&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://reportsweb.com/Global-Biologics-and-Biosimilars-Industry-2016-Market-Research-Report&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://reportsweb.com/Global-Biologics-and-Biosimilars-Industry-2016-Market-Research-Report&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments